SCHEMBL23902882

SCHEMBL23902882

O=c1c2c(ccc3[nH]c4ccccc4c32)sc2nc3ccccc3n12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.53
NPC1 O15118 4/20 0.53
RAB9A P51151 4/20 0.53
HSD17B10 Q99714 3/20 0.53
TP53 P04637 3/20 0.53
LMNA P02545 2/20 0.53
HPGD P15428 2/20 0.53
KDM4E B2RXH2 2/20 0.53
MAPT P10636 4/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
ALDH1A1 P00352 1/20 0.41
ALOX15 P16050 1/20 0.41
MAPK1 P28482 1/20 0.41
APOBEC3G Q9HC16 1/20 0.41
POLB P06746 1/20 0.41
ENPP1 P22413 7/20 0.41
TSHR P16473 1/20 0.40
GAA P10253 1/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23903155 0.79 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9AHSD17B10TP53
SCHEMBL23903089 0.76 SMN1; SMN2 (0.78) SMN1; SMN2NPC1RAB9AHSD17B10TP53
SCHEMBL23902884 0.75 KDM4E (0.48) SMN1; SMN2NPC1RAB9AHSD17B10TP53
SCHEMBL16441955 0.74 KDM4E (0.44) SMN1; SMN2NPC1RAB9AHSD17B10TP53
SCHEMBL23902923 0.73 NPC1 (0.54) SMN1; SMN2NPC1RAB9AHSD17B10TP53
SCHEMBL17996899 0.72 KDM4E (0.43) SMN1; SMN2NPC1HSD17B10TP53LMNA
SCHEMBL23902929 0.72 SMN1; SMN2 (0.50) SMN1; SMN2NPC1RAB9AHSD17B10TP53
SCHEMBL23902950 0.71 KDM4E (0.55) SMN1; SMN2NPC1RAB9AHSD17B10TP53
SCHEMBL16066271 0.70 KDM4E (0.44) SMN1; SMN2NPC1RAB9AHSD17B10TP53
SCHEMBL16066258 0.70 KDM4E (0.44) SMN1; SMN2NPC1RAB9AHSD17B10TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151026-A1 MULTI-LAYER BODY FOR DIFFUSE TRANSILLUMINATION MERCK PATENT GMBH (DE) 2023-05-18 US disclosed
US-20230151026-A1 MULTI-LAYER BODY FOR DIFFUSE TRANSILLUMINATION MERCK PATENT GMBH (DE) 2023-05-18 US disclosed
WO-2021198213-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-10-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151026-A1 MULTI-LAYER BODY FOR DIFFUSE TRANSILLUMINATION DDT, EPCAM, SLC18A3 SMN1; SMN2 4769/4885NPC1 1782/4885RAB9A 1937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.